FDA Update to Abortion Pill Label Aligns Care with Scientific Evidence, Improves Access to Early Abortion
FOR IMMEDIATE RELEASE
March 30, 2016
Contact: Christie Petrone, 646-520-3504, email@example.com
Statement by Andrea Miller, President of the National Institute for Reproductive Health
“Today’s announcement by the FDA ensures that the drug label on mifepristone will now match what medical providers and organizations have long considered the standard of care.
“This change is a welcome and overdue adjustment with the […]